Sex hormone–binding globulin and risk of hyperglycemia in patients with androgenetic alopecia - 28/07/11
, María Teresa Gutiérrez-Salmerón, PhD, Agustín Buendía-Eisman, PhD, María Sierra Girón-Prieto, MD, Ramón Naranjo-Sintes, PhD
Reprint requests: Salvador Arias-Santiago, PhD, San Cecilio University Hospital, Av Dr. Oloriz 16, Granada, 18012, Spain.Abstract |
Background |
Low circulating levels of sex hormone–binding globulin (SHBG) are a strong predictor of the risk of type 2 diabetes. Androgenetic alopecia (AGA) has been related to an increase in cardiovascular risk, but the mechanism of this association has not been elucidated. AGA can be associated with low levels of SHBG and insulin resistance, which could be related to hyperglycemia and type 2 diabetes.
Objective |
The objective of this study was to evaluate SHBG and blood glucose levels in men and women with early-onset AGA and control subjects to determine whether low levels of SHBG are associated with hyperglycemia.
Methods |
This case-control study included 240 patients consecutively admitted to the outpatient clinic (Dermatology Department of San Cecilio University Hospital, Granada, Spain), 120 with early-onset AGA (60 men and 60 women) and 120 control subjects (60 men and 60 women) with skin diseases other than alopecia.
Results |
Of patients with AGA, 39.1% presented with hyperglycemia (>110 mg/dL) versus 12.5% of controls (P < 0.0001). AGA patients with hyperglycemia or diabetes presented lower significant levels of SHBG than alopecic patients without hyperglycemia or type 2 diabetes, respectively. Patients with AGA and hyperglycemia presented significantly lower levels of SHBG than controls with hyperglycemia (22.3 vs 39.4 nmol/L for AGA patients and controls, respectively, P = .004). No significant differences in SHBG levels were noticed between patients and controls without hyperglycemia. Binary logistic regression showed a strong association between lower SHBG levels and glucose levels greater than 110 mg/dL in patients with AGA even after additional adjustment for sex, abdominal obesity, and free testosterone (odds ratio = 3.35; 95% confidence interval = 1.9-5.7; P < .001).
Limitations |
The study of a wider sample of AGA patients would confirm these findings and would permit analysis of the pathogenic mechanisms underlying the increase in cardiovascular risk in patients with AGA.
Conclusion |
An association between early-onset AGA, hyperglycemia/diabetes, and low levels of SHBG was observed in the current study. Low levels of SHBG could be a marker of insulin resistance and hyperglycemia/diabetes in patients with AGA.
Le texte complet de cet article est disponible en PDF.Key words : abdominal obesity, androgenetic alopecia, HOMA-IR index, hyperglycemia, insulin levels, SHBG, testosterone, type 2 diabetes
Abbreviations used : AGA, ATP-III, BMI, CI, HOMA-IR, OR, SHBG
Plan
| Funding sources: None. |
|
| Conflicts of interest: None declared. |
Vol 65 - N° 1
P. 48-53 - juillet 2011 Retour au numéro
Article précédent
- Analysis of familial factors using the basic and specific (BASP) classification in Korean patients with androgenetic alopecia
- Won-Soo Lee, Yoonseok Oh, Jae Hong Ji, Jang Kyu Park, Do Won Kim, Woo-Young Sim, Hyung Ok Kim, Seon-Wook Hwang, Tae Young Yoon, Young Chul Kye, Gwang Seong Choi, Moon-Bum Kim, Chang-Hoon Huh, Byung In Ro, Seong-Jin Kim, Jae-Hong Kim, Yoonhee Lee
- Efficacy of tacrolimus 0.1% ointment in cutaneous lupus erythematosus: A multicenter, randomized, double-blind, vehicle-controlled trial
- Annegret Kuhn, Kristina Gensch, Merle Haust, Stefan W. Schneider, Gisela Bonsmann, Noemi Gaebelein-Wissing, Percy Lehmann, Annette Wons, Peter Reitmeir, Vincent Ruland, Thomas A. Luger, Thomas Ruzicka
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?